Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Cancer Prev Res (Phila). 2018 Feb;11(2):113-119. doi: 10.1158/1940-6207.CAPR-17-0245. Epub 2017 Nov 22.
In breast adipose tissue, macrophages that encircle damaged adipocytes form "crown-like structures of breast" (CLS-B). Although CLS-B have been associated with breast cancer, their role in benign breast disease (BBD) and early carcinogenesis is not understood. We evaluated breast biopsies from three age-matched groups ( = 86 each, mean age 55 years), including normal tissue donors of the Susan G. Komen for the Cure Tissue Bank (KTB), and subjects in the Mayo Clinic Benign Breast Disease Cohort who developed cancer (BBD cases) or did not develop cancer (BBD controls, median follow-up 14 years). Biopsies were classified into histologic categories, and CD68-immunostained tissue sections were evaluated for the frequency and density of CLS-B. Our data demonstrate that CLS-B are associated with BBD: CLS-B-positive samples were significantly less frequent among KTB biopsies (3/86, 3.5%) than BBD controls (16/86 = 18.6%, = 0.01) and BBD cases (21/86 = 24%, = 0.002). CLS-B were strongly associated with body mass index (BMI); BMI < 25: 7% CLS-B positive, BMI 25-29: 13%, and BMI ≥ 30: 29% ( = 0.0005). Among BBD biopsies, a high CLS-B count [>5 CLS-B/sample: 10.5% (BBD cases) vs 4.7% (BBD controls), = 0.007] conferred a breast cancer OR of 6.8 (95% CI, 1.4-32.4), = 0.02, after adjusting for adipose tissue area (cm), histologic impression, and BMI. As high CLS-B densities are independently associated with an increased breast cancer risk, they may be a promising histologic marker of breast cancer risk in BBD. .
在乳腺脂肪组织中,包围受损脂肪细胞的巨噬细胞形成“乳腺癌样冠状结构”(CLS-B)。尽管 CLS-B 与乳腺癌有关,但它们在良性乳腺疾病(BBD)和早期癌变中的作用尚不清楚。我们评估了三个年龄匹配组(每组 86 例,平均年龄 55 岁)的乳腺活检,包括 Susan G. Komen for the Cure Tissue Bank(KTB)的正常组织供体,以及 Mayo 诊所良性乳腺疾病队列中发生癌症(BBD 病例)或未发生癌症(BBD 对照,中位随访 14 年)的患者。活检标本分为组织学类别,并评估 CD68 免疫染色组织切片中 CLS-B 的频率和密度。我们的数据表明 CLS-B 与 BBD 相关:在 KTB 活检中,CLS-B 阳性样本明显少于 BBD 对照组(3/86,3.5%)和 BBD 病例(21/86,24%)(=0.01 和 0.002)。CLS-B 与体重指数(BMI)密切相关;BMI<25:7%CLS-B 阳性,BMI25-29:13%,BMI≥30:29%(=0.0005)。在 BBD 活检中,高 CLS-B 计数[>5CLS-B/标本:10.5%(BBD 病例)与 4.7%(BBD 对照),=0.007]使乳腺癌的 OR 为 6.8(95%CI,1.4-32.4),=0.02,调整脂肪组织面积(cm)、组织学印象和 BMI 后。由于高 CLS-B 密度与乳腺癌风险增加独立相关,因此它们可能是 BBD 中乳腺癌风险的有前途的组织学标志物。